Kiniksa Pharmaceuticals International, plc

KNSA · Healthcare · Kiniksa Pharmaceuticals International, plc, a biopharmaceutical company, develops and commercializes medical therapies in the United States…

Kiniksa Pharmaceuticals International, plc (KNSA), in the Healthcare sector, has 26 disclosed filings on Paydirt over the trailing twelve months from 8 corporate insiders: 0 purchases and 26 sales. Filers took a median of 2 days from execution to disclosure, and the most recent trade was executed Sep 3 and filed Sep 3. The most active filer was Eben Tessari with 21 filings.

Add to watchlist

Filings, ttm

0 buys · 26 sells

Traders, ttm

8 insiders

Volume, ttmiDollar value disclosed in the window

$61.7M

estimated for Congress, as filed for insiders

Median delay

execution to disclosure

Last traded

Sep 3

Filed Sep 3

ADViAverage daily dollar volume

$60.8M

market data

Share price · 12M

$77.91 (+115.9%)

Adjusted for splits and dividends.

Volume by month

Buys $0 Sells $101.6M

Estimated for Congress, as filed for insiders · by filing month · past 24 months

Who filed

Eben Tessari CHIEF OPERATING OFFICER 21 filings MR

Mark Ragosa CHIEF FINANCIAL OFFICER 13 filings MM

Michael R Megna CHIEF ACCOUNTING OFFICER 9 filings SP

Sanj K Patel CHAIRMAN & CEO 7 filings RM

Ross Moat CHIEF OPERATING OFFICER 6 filings BQ

Barry D Quart Director 6 filings JP

John F. Paolini CHIEF MEDICAL OFFICER 4 filings GC

G Bradley Cole Director 1 filing

Recent filings

Michael R MegnaSALE CHIEF ACCOUNTING OFFICER $369K
4,600 sh × $80.30
Exec Sep 3
Filed Sep 3 · 4:40 PM ET G Bradley ColeSALE Director $299K
3,673 sh × $81.43
Exec Jul 29
Filed Jul 31 · 4:34 PM ET John F. PaoliniSALE CHIEF MEDICAL OFFICER $3.1M
58,424 sh across 2 lots
Exec May 1
Filed May 5 · 5:30 PM ET Sanj K PatelSALE CHAIRMAN & CEO $2.6M
48,565 sh × $54.02
Exec May 1
Filed May 1 · 5:30 PM ET Sanj K PatelSALE CHAIRMAN & CEO $26.4M
508,339 sh across 6 lots
Exec Apr 28
Filed Apr 30 · 5:30 PM ET Barry D QuartSALE Director $656K
13,099 sh × $50.10
Exec Apr 28
Filed Apr 29 · 5:30 PM ET Michael R MegnaSALE CHIEF ACCOUNTING OFFICER $309K
6,625 sh × $46.69
Exec Apr 9
Filed Apr 13 · 5:30 PM ET Barry D QuartSALE Director $345K
6,901 sh × $50.00
Exec Apr 6
Filed Apr 8 · 5:30 PM ET Ross MoatSALE CHIEF OPERATING OFFICER $115K
2,367 sh × $48.58
Exec Apr 6
Filed Apr 8 · 5:30 PM ET Sanj K PatelSALE CHAIRMAN & CEO $364K
7,278 sh × $50.01
Exec Apr 6
Filed Apr 8 · 5:30 PM ET Mark RagosaSALE CHIEF FINANCIAL OFFICER $1.7M
36,722 sh across 2 lots
Exec Mar 9
Filed Mar 11 · 5:30 PM ET John F. PaoliniSALE CHIEF MEDICAL OFFICER $1.8M
40,000 sh across 3 lots
Exec Mar 2
Filed Mar 4 · 5:30 PM ET Barry D QuartSALE Director $121K
2,690 sh × $45.00
Exec Feb 12
Filed Feb 12 · 5:30 PM ET Mark RagosaSALE CHIEF FINANCIAL OFFICER $772K
17,845 sh across 2 lots
Exec Feb 9
Filed Feb 11 · 5:30 PM ET Barry D QuartSALE Director $684K
15,130 sh across 2 lots
Exec Feb 3
Filed Feb 4 · 5:30 PM ET Mark RagosaSALE CHIEF FINANCIAL OFFICER $503K
12,000 sh × $41.89
Exec Jan 8
Filed Jan 9 · 5:30 PM ET Eben TessariSALE CHIEF OPERATING OFFICER $501K
12,048 sh × $41.56
Exec Dec 15 2025
Filed Dec 17 2025 · 5:30 PM ET Barry D QuartSALE Director $836K
20,129 sh × $41.51
Exec Dec 15 2025
Filed Dec 17 2025 · 5:30 PM ET Mark RagosaSALE CHIEF FINANCIAL OFFICER $1.8M
42,841 sh × $41.49
Exec Dec 8 2025
Filed Dec 10 2025 · 5:30 PM ET Eben TessariSALE CHIEF OPERATING OFFICER $488K
11,825 sh × $41.30
Exec Nov 17 2025
Filed Nov 19 2025 · 5:30 PM ET Mark RagosaSALE CHIEF FINANCIAL OFFICER $815K
19,900 sh × $40.94
Exec Nov 12 2025
Filed Nov 14 2025 · 5:30 PM ET John F. PaoliniSALE CHIEF MEDICAL OFFICER $3.1M
82,542 sh × $37.14
Exec Oct 31 2025
Filed Nov 4 2025 · 5:30 PM ET Michael R MegnaSALE CHIEF ACCOUNTING OFFICER $2.0M
50,490 sh across 2 lots
Exec Oct 20 2025
Filed Oct 22 2025 · 5:30 PM ET Sanj K PatelSALE CHAIRMAN & CEO $10.0M
257,969 sh across 4 lots
Exec Oct 20 2025
Filed Oct 22 2025 · 5:30 PM ET Eben TessariSALE CHIEF OPERATING OFFICER $445K
11,815 sh × $37.65
Exec Oct 14 2025
Filed Oct 16 2025 · 5:30 PM ET